Allergy Immunotherapy Market Share

Statistics for the 2023 & 2024 Allergy Immunotherapy market share, created by Mordor Intelligence™ Industry Reports. Allergy Immunotherapy share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Allergy Immunotherapy Industry

The market studied is a consolidated market owing to the presence of a few major market players. The competitive landscape includes an analysis of a few international as well as regional companies which hold the market shares and are well known including Aimmune Therapeutics, Hollister Allergy, Leti Pharma, Merck KGaA (Allergopharma), Stallergenes Greer, Allergy Therapeutics, ALK-Abello A/S, HAL Allergy Group, Biomay AG, and Circassia among others.

Allergy Immunotherapy Market Leaders

  1. Merck KGaA (Allergopharma)

  2. Jubliant Pharma (Hollister Allergy)

  3. Leti Pharma

  4. Stallergenes Greer

  5. ALK-Abello A/S

*Disclaimer: Major Players sorted in no particular order

Allergy Immunotherapy Market

Allergy Immunotherapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)